Related references
Note: Only part of the references are listed.Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance
Sonja C. Bernhard et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate
Naomi Maina et al.
ACTA TROPICA (2007)
Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series
Francesco Checchi et al.
PLOS NEGLECTED TROPICAL DISEASES (2007)
Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes
Daniel J. Bridges et al.
MOLECULAR PHARMACOLOGY (2007)
Drugs and drug resistance in African trypanosomiasis
Vincent Delespaux et al.
DRUG RESISTANCE UPDATES (2007)
Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance
Charlotte A. Lanteri et al.
MOLECULAR PHARMACOLOGY (2006)
Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test
ML Stewart et al.
LANCET (2005)
The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in African trypanosomes
HP de Koning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Real-time PCR for detection of Trypanosoma brucei in human blood samples
S Becker et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei
E Matovu et al.
EUKARYOTIC CELL (2003)
Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter
HP de Koning et al.
ACTA TROPICA (2001)
The phenomenon of treatment failures in Human African Trypanosomiasis
R Brun et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy
E Matovu et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment
C Burri et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Re-emergence of epidemic sleeping sickness in southern Sudan
A Moore et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Melarsoprol refractory T-b. gambiense from Omugo, north-western Uganda
E Matovu et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Further evidence for a link between melarsoprol resistance and P2 transporter function in African trypanosomes
HP de Koning et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Share Paper
